Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
BlackRock Inc. BLK |
3,101,030 6.600% |
3,101,030 (New Position) |
Filing History |
| 2022-01-18 4:28 pm Unchanged |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Cowen Financial Products LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-01-14 1:29 pm Sale |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Cowen Financial Products LLC | 0 0.000% |
-2,015,513 (Position Closed) |
Filing History |
| 2021-10-12 09:25 am Purchase |
2021-10-08 | 13G | Celldex Therapeutics, Inc. CLDX |
FMR LLC | 5,615,333 12.080% |
5,615,333 (New Position) |
Filing History |
| 2021-02-25 3:50 pm Purchase |
2021-02-22 | 13G | Celldex Therapeutics, Inc. CLDX |
Cowen Financial Products LLC | 2,015,513 5.094% |
2,015,513 (New Position) |
Filing History |
| 2021-02-16 4:07 pm Purchase |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Redmile Group LLC | 2,711,616 6.900% |
2,711,616 (New Position) |
Filing History |
| 2021-02-12 4:32 pm Sale |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Ikarian Capital LLC | 1,364,990 3.500% |
-227,449 (-14.28%) |
Filing History |
| 2021-02-12 09:52 am Purchase |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW INVESTMENTS LP | 3,422,855 8.660% |
1,537,855 (+81.58%) |
Filing History |
| 2021-02-11 4:33 pm Sale |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,740,000 (Position Closed) |
Filing History |
| 2021-02-11 07:39 am Purchase |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 2,500,000 6.320% |
600,000 (+31.58%) |
Filing History |
| 2021-02-10 4:51 pm Sale |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
RENAISSANCE TECHNOLOGIES LLC | 1,048,827 2.650% |
-66,541 (-5.97%) |
Filing History |
| 2020-10-22 12:27 pm Purchase |
2020-06-16 | 13G | Celldex Therapeutics, Inc. CLDX |
Logos Global Management LP | 1,700,000 4.300% |
1,700,000 (New Position) |
Filing History |